US provider directory / Profile

knownwell

Weight-inclusive primary and metabolic care delivered through clinics and virtual care, with insurance participation in selected markets.

Leer el resumen en español ↓
  • Insurance help
  • Brand route
  • Coaching
  • Switching support
Research checkedSep 13, 2026
4 cited sourcesUS profile
Editorial note

This profile describes access and programme structure. Inclusion is not an endorsement, regulatory finding, or clinical recommendation. Prescription decisions belong to a qualified prescriber.

At a glance

Price viewNo membership; average insured visit $31knownwell reports a $31 average insured visit cost. Actual visit, lab, and medication cost depends on plan/deductible; self-pay is visit-based.
Payment routesInsurance help · Cash payConfirm plan participation for the relevant clinician and site of care.
Medicines and brand contextSemaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)Only if prescribed, appropriate, and available for the relevant indication.
GeographyNationwide virtual clinic plus selected in-person markets; clinician licensure appliesConfirm during intake.
Service modelPrimary and metabolic careClinic
Format and supportInjection · Oral medicineCoaching · Clinician support · Switching pathway · Home delivery
Evidence reviewed4 cited sources

Pricing, medicine, location, care, fulfilment, funding, and policy claims are separated below.

Still to confirm4 open checks

An open check means the public sources were not specific enough—not that the service failed the check.

Resumen en español

knownwell para usuarios hispanohablantes

Idioma de la consulta no confirmado

Esta sección ofrece una orientación breve en español sobre el perfil estadounidense. La investigación completa de precios, acceso, farmacia y seguimiento permanece arriba mientras ampliamos la revisión editorial en español.

Mercado revisadoEstados Unidos
Forma de pagoSeguro médico · Pago directo
Ruta publicadaMedicamento de marca
Idioma de la atención

No encontramos una fuente primaria suficientemente específica para afirmar que una cita clínica esté disponible en español. Confirma el idioma y cualquier servicio de interpretación antes de pagar.

Antes de pagar, confirma:
  • si la cita concreta será en español;
  • el coste mensual ordinario y qué incluye;
  • la licencia estatal del profesional;
  • el medicamento, la farmacia y el coste por separado.

Esta traducción editorial no demuestra que el proveedor ofrezca atención clínica en español y no sustituye una valoración médica.

Comparar proveedores para hispanohablantes en EE. UU. →

How the program is structured

A visit-based obesity-medicine clinic rather than a medication subscription. There is no membership fee; patients use insurance or self-pay for longer visits with the same clinician, with monthly early follow-ups, nutrition, coaching, prior authorization, and ordinary pharmacy fulfillment.

GLP.directory checked the cited public sources on Sep 13, 2026. We reviewed published access, cost, care, fulfilment, funding, cancellation, monitoring, and switching details; we have not audited individual clinical encounters, prescriptions, pharmacy operations, or outcomes.

Availability can change by state, clinician, medical history, product, pharmacy, inventory, and insurance plan. “Not publicly confirmed” means we did not find a sufficiently specific answer in the cited public material. Confirm the current patient-specific answer before paying or changing care.

Research confidence High Confidence reflects public-source specificity, not clinical quality.

Service configuration

These structured fields power the directory filters. They describe the reviewed public route and should be reconfirmed for the selected plan.

Provider type
Clinic
Medicine context
Semaglutide (Wegovy; Ozempic/Rybelsus for type 2 diabetes) · Tirzepatide (Zepbound; Mounjaro for type 2 diabetes) · Liraglutide (Saxenda; Victoza for type 2 diabetes)
Formats reviewed
Injection · Oral medicine
Funding routes
Insurance support · Private pay
Service features
Coaching · Clinician support · Switching pathway · Home delivery
Access check
Confirm current state access
Evidence status
Primary sources reviewed
Research depth
4 cited sources · 4 medicine rows · 4 open checks

Recurring cost breakdown

  • No membership fee; the patient pays per visit or insurance cost-sharing.
  • The company reports an average $31 visit cost with insurance.
  • Medication, labs, copays, and deductibles are separate.
  • Self-pay appointments are paid when scheduled; exact service prices are listed by the clinic.
Build the actual monthly total from
  • Medicine + dose
  • Membership or consultation
  • Delivery + supplies
  • Labs + follow-up
  • Renewal after offers

Medication and formulation matrix

MedicationFormRegulatory / program pathPublished price view
WegovyDaily pill / weekly penFDA-approved brandInsurance copay or out-of-pocket manufacturer/pharmacy price
ZepboundKwikPen, vial or penFDA-approved brandInsurance copay or LillyDirect route
Ozempic / Saxenda / FoundayoInjection or pillFDA-approved brands; indications differCoverage or cash route dependent
Contrave and generic alternativesOralFDA-approved/clinician-selectedCoverage or pharmacy price

Important: “Compounded” means the product is not FDA approved. A brand approved for one condition is not automatically approved for another. The treating clinician determines whether any prescription is appropriate.

State-by-state availability

  • A nationwide virtual clinic is advertised, subject to a clinician licensed where the patient is physically located.
  • In-person clinics are listed in California, Georgia, Illinois, Massachusetts, and New York, with Texas rollout shown separately at review.

Clinician access and follow-up cadence

  • New metabolic consultations average 40 minutes; follow-ups average 15–20 minutes.
  • The same clinician is used across visits where possible.
  • Monthly visits are advertised while getting started; ongoing cadence then follows the care plan.
  • App messaging and coaching support are available.

Pharmacy and fulfillment

  • The care team can route prescriptions to several pharmacies, including manufacturer channels such as LillyDirect or NovoCare where eligible.
  • A universal pharmacy is not used; select the option that fits coverage and location.

Insurance and prior authorization

  • knownwell is in-network with many commercial plans and Medicare.
  • The team checks coverage, handles prior authorization, identifies copay cards and pharmacy discounts, and advocates after denial.
  • Most plans require prior authorization for GLP-1 coverage; outcome remains plan-specific.

Cancellation, refund, and commitment

  • There is no subscription to cancel.
  • Appointments canceled more than 24 hours ahead receive a full self-pay refund; late cancellation or no-show carries a $50 fee.

Labs, monitoring, and dose management

  • Labs are sometimes required depending on medication and history.
  • Follow-up is required for ongoing prescriptions, though not for every refill.
  • Lab and visit billing follow ordinary insurance/self-pay channels.

Maintenance and switching

  • The same-clinician model and nutrition/coaching services are suited to long-term management.
  • Care-team timing and record transfer should be arranged before changing pharmacies or prescribers.

Program snapshot

Care model

Primary and metabolic care

Profiled support: Ongoing clinician access, Coaching or behavior support.

Payment and coverage

Insurance help · Cash pay

Confirm plan participation for the relevant clinician and site of care.

Pharmacy and fulfillment

Verify before purchase

Prescriptions follow ordinary pharmacy channels; medication is not bundled into the profile price.

What the advertised program may include

  • Primary and metabolic care
  • Clinician follow-up
  • Insurance billing in participating markets
  • Medication management when appropriate

Useful comparison signals

Based on the provider’s published program structure, this profile is tagged for the following searches. These are filters, not endorsements or clinical recommendations.

  • Starting care and comparing first-provider requirements
  • Switching providers or continuing an established treatment
  • Ongoing clinician access
  • Coaching or behavior support

Open evidence gaps

These are material details we could not confirm precisely enough from the cited public pages. They are the highest-priority questions to resolve directly.

  • Net medication price before benefit review
  • Clinician availability in every state at every date
  • Fixed long-term follow-up schedule
  • Pharmacy inventory guarantees

Questions to ask before paying

  1. What is the ordinary recurring total after any introductory period?
  2. Does that total include clinician care, medication, supplies, labs, and shipping?
  3. Which clinician group and dispensing pharmacy will be responsible for my care?
  4. What happens to billing if I am not prescribed the advertised treatment?
  5. What records and timing do you require if I am switching from another provider?

Source ledger

Every entry below is a provider-controlled or official public source. A source link documents what was published; it does not independently validate performance, regulatory compliance, safety, or outcomes.